[
  {
    "ts": "2025-08-13T04:30:00+00:00",
    "headline": "[Latest] Global Canine Orthopedics Market Size/Share Worth USD 945.2 Million by 2034 at a 8.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)",
    "summary": "[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Canine Orthopedics Market size & share revenue was valued at approximately USD 420.2 Million in 2024 and is expected to reach USD 454.6 Million in 2025 and is expected to reach around USD 945.2 Million by 2034, at a CAGR of 8.6% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are B. Braun Melsungen AG, Movo",
    "url": "https://finance.yahoo.com/news/latest-global-canine-orthopedics-market-043000764.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "8668a5aa-58cb-3f16-b6e5-5dee330045d6",
      "content": {
        "id": "8668a5aa-58cb-3f16-b6e5-5dee330045d6",
        "contentType": "STORY",
        "title": "[Latest] Global Canine Orthopedics Market Size/Share Worth USD 945.2 Million by 2034 at a 8.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)",
        "description": "",
        "summary": "[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Canine Orthopedics Market size & share revenue was valued at approximately USD 420.2 Million in 2024 and is expected to reach USD 454.6 Million in 2025 and is expected to reach around USD 945.2 Million by 2034, at a CAGR of 8.6% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are B. Braun Melsungen AG, Movo",
        "pubDate": "2025-08-13T04:30:00Z",
        "displayTime": "2025-08-13T04:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/0bec09301614ea6a3ee415db83086891",
          "originalWidth": 2514,
          "originalHeight": 1281,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/2CrZC42kgw2SjdY2CY6ucw--~B/aD0xMjgxO3c9MjUxNDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/0bec09301614ea6a3ee415db83086891.cf.webp",
              "width": 2514,
              "height": 1281,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/91DUI4_rVm8Et9pJYV6I4Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/0bec09301614ea6a3ee415db83086891.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/latest-global-canine-orthopedics-market-043000764.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/latest-global-canine-orthopedics-market-043000764.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VIMIAN.ST"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "STE"
            },
            {
              "symbol": "ZTS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-08-13T04:19:21+00:00",
    "headline": "ZTS Q2 Deep Dive: Market Questions Librela Outlook Amid Double-Digit Growth in Core Franchises",
    "summary": "Animal health company Zoetis (NYSE:ZTS) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 4.2% year on year to $2.46 billion. The company expects the full year’s revenue to be around $9.53 billion, close to analysts’ estimates. Its non-GAAP profit of $1.76 per share was 9.2% above analysts’ consensus estimates.",
    "url": "https://finance.yahoo.com/news/zts-q2-deep-dive-market-041921271.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "af9f8648-e51f-3fbf-83e6-82a08f7fb846",
      "content": {
        "id": "af9f8648-e51f-3fbf-83e6-82a08f7fb846",
        "contentType": "STORY",
        "title": "ZTS Q2 Deep Dive: Market Questions Librela Outlook Amid Double-Digit Growth in Core Franchises",
        "description": "",
        "summary": "Animal health company Zoetis (NYSE:ZTS) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 4.2% year on year to $2.46 billion. The company expects the full year’s revenue to be around $9.53 billion, close to analysts’ estimates. Its non-GAAP profit of $1.76 per share was 9.2% above analysts’ consensus estimates.",
        "pubDate": "2025-08-13T04:19:21Z",
        "displayTime": "2025-08-13T04:19:21Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/a3d0b8410287a32b42c8f0447c66312e",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "ZTS Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ZIV_z_HWBQbAZAdlIXH86g--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/a3d0b8410287a32b42c8f0447c66312e.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/2wbi11nRtAIpjCwNsAitnA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/a3d0b8410287a32b42c8f0447c66312e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/zts-q2-deep-dive-market-041921271.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/zts-q2-deep-dive-market-041921271.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ZTS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-08-13T04:02:40+00:00",
    "headline": "5 Revealing Analyst Questions From Zoetis’s Q2 Earnings Call",
    "summary": "Zoetis’ second quarter saw revenue and adjusted earnings surpass Wall Street expectations, but the market responded negatively, reflecting skepticism over the company’s performance trajectory. Management highlighted robust operational growth across its Companion Animal and Livestock segments, crediting strong execution in the Simparica and Key Dermatology franchises as major contributors. CEO Kristin Peck emphasized the enduring strength of Zoetis’ diversified portfolio despite competitive press",
    "url": "https://finance.yahoo.com/news/5-revealing-analyst-questions-zoetis-040240591.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "9c298062-3183-35f2-94b3-0aec82ab5ae1",
      "content": {
        "id": "9c298062-3183-35f2-94b3-0aec82ab5ae1",
        "contentType": "STORY",
        "title": "5 Revealing Analyst Questions From Zoetis’s Q2 Earnings Call",
        "description": "",
        "summary": "Zoetis’ second quarter saw revenue and adjusted earnings surpass Wall Street expectations, but the market responded negatively, reflecting skepticism over the company’s performance trajectory. Management highlighted robust operational growth across its Companion Animal and Livestock segments, crediting strong execution in the Simparica and Key Dermatology franchises as major contributors. CEO Kristin Peck emphasized the enduring strength of Zoetis’ diversified portfolio despite competitive press",
        "pubDate": "2025-08-13T04:02:40Z",
        "displayTime": "2025-08-13T04:02:40Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/a3d0b8410287a32b42c8f0447c66312e",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "ZTS Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ZIV_z_HWBQbAZAdlIXH86g--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/a3d0b8410287a32b42c8f0447c66312e.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/2wbi11nRtAIpjCwNsAitnA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/a3d0b8410287a32b42c8f0447c66312e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/5-revealing-analyst-questions-zoetis-040240591.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/5-revealing-analyst-questions-zoetis-040240591.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ZTS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]